XWELL (NASDAQ:XWEL) Trading 0.9% Higher – Time to Buy?

Shares of XWELL, Inc. (NASDAQ:XWELGet Free Report) rose 0.9% on Thursday . The company traded as high as $1.10 and last traded at $1.07. 24,013 shares traded hands during trading, a decline of 77% from the average session volume of 102,763 shares. The stock had previously closed at $1.06.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on XWEL shares. Weiss Ratings lowered shares of XWELL from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 13th. Wall Street Zen downgraded shares of XWELL from a “hold” rating to a “sell” rating in a research note on Sunday, May 17th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, XWELL currently has an average rating of “Sell”.

Read Our Latest Research Report on XWELL

XWELL Price Performance

The stock has a market capitalization of $9.03 million, a P/E ratio of -0.19 and a beta of 1.03. The company has a fifty day moving average of $1.26 and a two-hundred day moving average of $0.97.

XWELL (NASDAQ:XWELGet Free Report) last announced its quarterly earnings data on Wednesday, May 20th. The company reported ($1.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.00) by ($0.51). XWELL had a negative net margin of 81.43% and a negative return on equity of 2,318.99%. The firm had revenue of $6.64 million for the quarter, compared to analyst estimates of $2.37 million.

About XWELL

(Get Free Report)

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.

Read More

Receive News & Ratings for XWELL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XWELL and related companies with MarketBeat.com's FREE daily email newsletter.